diazomethane has been researched along with Protein Aggregation, Pathological in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Araya, T; Kanai, M; Kino, R; Sohma, Y | 1 |
1 other study(ies) available for diazomethane and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Diazomethane; Humans; Peptide Fragments; Peptides, Cyclic; Protein Aggregates; Protein Aggregation, Pathological; Rats | 2015 |